Abstract
Rationale
Methamphetamine (MA) addiction is a major public health issue in the USA, with a poorly understood genetic component. We previously identified heterogeneous nuclear ribonucleoprotein H1 (Hnrnph1; H1) as a quantitative trait gene underlying sensitivity to MA-induced behavioral sensitivity. Mice heterozygous for a frameshift deletion in the first coding exon of H1 (H1+/−) showed reduced MA phenotypes including oral self-administration, locomotor activity, dopamine release, and dose-dependent differences in MA conditioned place preference. However, the effects of H1+/− on innate and MA-modulated reward sensitivity are not known.
Objectives
We examined innate reward sensitivity and facilitation by MA in H1+/− mice via intracranial self-stimulation (ICSS).
Methods
We used intracranial self-stimulation (ICSS) of the medial forebrain bundle to assess shifts in reward sensitivity following acute, ascending doses of MA (0.5–4.0 mg/kg, i.p.) using a within-subjects design. We also assessed video-recorded behaviors during ICSS testing sessions.
Results
H1+/− mice displayed reduced normalized maximum response rates in response to MA. H1+/− females had lower normalized M50 values compared to wild-type females, suggesting enhanced reward facilitation by MA. Finally, regardless of genotype, there was a dose-dependent reduction in distance to the response wheel following MA administration, providing an additional measure of MA-induced reward-driven behavior.
Conclusions
H1+/− mice displayed a complex ICSS phenotype following MA, displaying indications of both blunted reward magnitude (lower normalized maximum response rates) and enhanced reward sensitivity specific to H1+/− females (lower normalized M50 values).
Similar content being viewed by others
References
Albers DS, Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275(3):1104–1114
Bauer CT, Banks ML, Blough BE, Negus SS (2013) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168(4):850–862. https://doi.org/10.1111/j.1476-5381.2012.02214.x
Bauer CT, Banks ML, Negus SS (2014) The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats. Psychopharmacology 231(12):2461–2470. https://doi.org/10.1007/s00213-013-3405-1
Bielajew C, Shizgal P (1986) Evidence implicating descending fibers in self-stimulation of the medial forebrain bundle. J Neurosci 6(4):919–929
Bousman CA, Glatt SJ, Everall IP, Tsuang MT (2009a) Genetic association studies of methamphetamine use disorders: a systematic review and synthesis. Am J Med Genet 150B(8):1025–1049. https://doi.org/10.1002/ajmg.b.30936
Bousman CA, Glatt SJ, Everall IP, Tsuang MT (2009b) Genetic association studies of methamphetamine use disorders: a systematic review and synthesis. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 150B(8):1025–1049. https://doi.org/10.1002/ajmg.b.30936
Bryant CD, Yazdani N (2016) RNA binding proteins, neural development and the addictions. Genes, Brain and Behavior 15:169–186
Carlezon WA, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987–2995
Chan P, Di Monte DA, Luo J et al (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62(6):2484–2487. https://doi.org/10.1046/j.1471-4159.1994.62062484.x
Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104(7):1085–1099. https://doi.org/10.1111/j.1360-0443.2009.02564.x
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. PNAS 85(14):5274–5278
Dluzen DE, McDermott JL (2008) Sex differences in dopamine- and vesicular monoamine-transporter functions. Ann N Y Acad Sci 1139:140–150. https://doi.org/10.1196/annals.1432.010
Dluzen DE, Bhatt S, McDermott JL (2008) Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function. Neuroscience 154(4):1488–1496
Esposito RU, Perry W, Kornetsky C (1980) Effects of d-amphetamine and naloxone on brain stimulation reward. Psychopharmacology 69(2):187–191. https://doi.org/10.1007/BF00427648
Fiorino DF, Coury A, Fibiger HC et al (1993) Electrical stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus accumbens of the rat. Behav Brain Res 55(2):131–141
Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, Malanga CJ (2012) Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine. Psychopharmacology 220(4):719–730. https://doi.org/10.1007/s00213-011-2523-x
Flint J, Valdar W, Shifman S, Mott R (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6:271–286
Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398(6722):67–69. https://doi.org/10.1038/18019
Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521–532
Han SP, Tang YH, Smith R (2010) Functional diversity of the hnRNPs: past, present and perspectives. Biochem J 430(3):379–392. https://doi.org/10.1042/BJ20100396
Hancock DB, Markunas CA, Bierut LJ, Johnson EO (2018) Human genetics of addiction: new insights and future directions. Curr Psychiatry Rep 20(2):8. https://doi.org/10.1007/s11920-018-0873-3
Ikeda M, Okahisa Y, Aleksic B, Won M, Kondo N, Naruse N, Aoyama-Uehara K, Sora I, Iyo M, Hashimoto R, Kawamura Y, Nishida N, Miyagawa T, Takeda M, Sasaki T, Tokunaga K, Ozaki N, Ujike H, Iwata N (2013) Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology 38:1864–1870
Jensen KP (2016) A review of genome-wide association studies of stimulant and opioid use disorders. Mol Neuropsychiatry 2(1):37–45. https://doi.org/10.1159/000444755
Johnson AR, Banks ML, Selley DE, Negus SS (2018) Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43(8):1753–1762. https://doi.org/10.1038/s41386-018-0071-3
Kesby JP, Chang A, Markou A, Semenova S (2018) Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry. Addict Biol 23(1):206–218. https://doi.org/10.1111/adb.12502
Kim VN, Kataoka N, Dreyfuss G (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3(3):195–205. https://doi.org/10.1038/nrm760
Koshikawa N, Mori E, Oka K et al (1989) Effects of SCH23390 injection into the dorsal striatum and nucleus accumbens on methamphetamine-induced gnawing and hyperlocomotion in rats. J Nihon Univ Sch Dent 31(2):451–457
Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chi Chin M, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, Desaki AL, Desta T, Diep E, Dolbeare TA, Donelan MJ, Dong HW, Dougherty JG, Duncan BJ, Ebbert AJ, Eichele G, Estin LK, Faber C, Facer BA, Fields R, Fischer SR, Fliss TP, Frensley C, Gates SN, Glattfelder KJ, Halverson KR, Hart MR, Hohmann JG, Howell MP, Jeung DP, Johnson RA, Karr PT, Kawal R, Kidney JM, Knapik RH, Kuan CL, Lake JH, Laramee AR, Larsen KD, Lau C, Lemon TA, Liang AJ, Liu Y, Luong LT, Michaels J, Morgan JJ, Morgan RJ, Mortrud MT, Mosqueda NF, Ng LL, Ng R, Orta GJ, Overly CC, Pak TH, Parry SE, Pathak SD, Pearson OC, Puchalski RB, Riley ZL, Rockett HR, Rowland SA, Royall JJ, Ruiz MJ, Sarno NR, Schaffnit K, Shapovalova NV, Sivisay T, Slaughterbeck CR, Smith SC, Smith KA, Smith BI, Sodt AJ, Stewart NN, Stumpf KR, Sunkin SM, Sutram M, Tam A, Teemer CD, Thaller C, Thompson CL, Varnam LR, Visel A, Whitlock RM, Wohnoutka PE, Wolkey CK, Wong VY, Wood M, Yaylaoglu MB, Young RC, Youngstrom BL, Feng Yuan X, Zhang B, Zwingman TA, Jones AR (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445(7124):168–176. https://doi.org/10.1038/nature05453
Lominac KD, McKenna CL, Schwartz LM et al (2014) Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation. Front Syst Neurosci 8:70. https://doi.org/10.3389/fnsys.2014.00070
Milesi-Hallé A, Hendrickson HP, Laurenzana EM, Gentry WB, Owens SM (2005) Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats. Toxicol Appl Pharmacol 209(3):203–213. https://doi.org/10.1016/j.taap.2005.04.007
Miliaressis E, Rompre P, Laviolette P et al (1986) The curve-shift paradigm in self-stimulation. Physiol Behav 37(1):85–91. https://doi.org/10.1016/0031-9384(86)90388-4
Miliaressis E, Emond C, Merali Z (1991) Re-evaluation of the role of dopamine in intracranial self-stimulation using in vivo microdialysis. Behav Brain Res 46(1):43–48
National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. National Academies Press (US), Washington (DC).
Negus SS, Miller LL (2014) Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev 66(3):869–917. https://doi.org/10.1124/pr.112.007419
Otani K, Ujike H, Sakai A, Okahisa Y, Kotaka T, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S (2008) Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence. Neurosci Lett 434(1):88–92. https://doi.org/10.1016/j.neulet.2008.01.033
Owesson-White CA, Cheer JF, Beyene M, Carelli RM, Wightman MR (2008) Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation. Proc Natl Acad Sci U S A 105(33):11957–11962. https://doi.org/10.1073/pnas.0803896105
Paxinos GT, Franklin KB (2004) The mouse brain in stereotaxic coordinates, 2 edn. Academic Press, San Diego, CA
Phillips AG, Blaha CD, Fibiger HC (1989) Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci Biobehav Rev 13(2-3):99–104
Riday TT, Kosofsky BE, Malanga CJ (2012) The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice. Neuropharmacology 62(4):1858–1866. https://doi.org/10.1016/j.neuropharm.2011.12.011
Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ (2012) Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behav Brain Res 234(1):76–81. https://doi.org/10.1016/j.bbr.2012.06.012
Ruan QT, Yazdani N, Reed ER, Beierle JA, Peterson LP, Luttik KP, Szumlinski KK, Johnson WE, Ash PEA, Wolozin B, Bryant CD (2020a) 5′ UTR variants in the quantitative trait gene Hnrnph1 support reduced 5′ UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity [published online ahead of print, 2020 May 13]. FASEB J 34:9223–9244. https://doi.org/10.1096/fj.202000092R
Ruan QT, Yazdani N, Blum BC, Beierle JA, Lin W, Coelho MA, Fultz EK, Healy AF, Shahin JR, Kandola AK, Luttik KP, Zheng K, Smith NJ, Cheung J, Mortazavi F, Apicco DJ, Ragu Varman D, Ramamoorthy S, Ash PEA, Rosene DL, Emili A, Wolozin B, Szumlinski KK, Bryant CD (2020b) A mutation in Hnrnph1 that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins. J Neurosci 40(1):107–130
Schultz W (2000) Multiple reward signals in the brain. Nat Rev Neurosci 1(3):199–207. https://doi.org/10.1038/35044563
Seth P, Scholl L, Rudd RA et al (2018) Overdose deaths involving opioids, cocaine, and psychostimulants – United States, 2015–2016. MMWR Morb Mortal Wkly Rep 67(12):349–358. https://doi.org/10.15585/mmwr.mm6712a1
Spanagel R (2013) Convergent functional genomics in addiction research – a translational approach to study candidate genes and gene networks. Silico Pharmacol 1(1):1–9. https://doi.org/10.1186/2193-9616-1-18
Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75(6):406–433. https://doi.org/10.1016/j.pneurobio.2005.04.003
Uhl GR, Drgon T, Liu Q et al (2008) Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry 65(3):345–355. https://doi.org/10.1001/archpsyc.65.3.345
Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD (2015) Hnrnph1 is a quantitative trait gene for methamphetamine sensitivity. PLoS Genet 11(12):e1005713
Zocchi A, Orsini C, Cabib S, Puglisi-Allegra S (1997) Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82(2):521–528. https://doi.org/10.1016/S0306-4522(97)00276-5
Acknowledgments
We thank Julia L. Scotellaro for assistance with genotyping, histology, and behavioral training. W.A.C. discloses that he has served as a paid consultant for Psy Therapeutics within the past 2 years.
Funding
This work was funded by R01DA039168 (C.D.B.), U01DA050243 (C.D.B.), NIGMS T32 Biomolecular Pharmacology Training Grant GM008541 (K.N.B.), and Boston University’s Transformative Training Program in Addiction Science (TTPAS Burroughs Wellcome Fund #1011479; K.N.B.).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 134 kb)
Rights and permissions
About this article
Cite this article
Borrelli, K.N., Langan, C.R., Dubinsky, K.R. et al. Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice. Psychopharmacology 238, 2031–2041 (2021). https://doi.org/10.1007/s00213-021-05829-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-021-05829-4